Stem-cell therapies should not be rushed
Japan is working on a process to fast-track its regulatory approval of induced pluripotent stem (iPS) cells for the treatment of Parkinson’s disease, as per local media reports. The country is reportedly preparing to apply for a fast-track regulatory approval for some products based on iPS cells, in some cases perhaps even within the year.
The impact of dogs on the environment can be mitigated by owners
Researchers have sequenced the complete genomes of six ape species, helping uncover Evolutionary History of our closest relatives and offering insights into what makes humans human. Human brain cells that were engineered to evade detection by the immune system restored muscle control in a rat model of Parkinson’s disease. The study is part of the process of developing a universal cell line.